• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Symbility Solutions Reports 2015 First Quarter Financial Results

    Kristen Moran
    May. 29, 2015 09:00AM PST
    Life Science Investing

    Symbility Solutions Inc. (TSXV:SY) announced its financial results for the 2015 first quarter, which showed a net loss of $1.0 million or $0.01 per share and a cash balance of $5.2 million.

    Symbility Solutions Inc. (TSXV:SY) announced its financial results for the 2015 first quarter, which showed a net loss of $1.0 million or $0.01 per share and a cash balance of $5.2 million.

    As quoted in the press release:

    In the three months ended March 31, 2015, consolidated revenue was $5 million, this compares to revenues of $7.2 million in the same period last year, which represents a decrease of 30 percent or $2.1 million.

    The net loss for the three months ending March 31, 2015, was $1.9 million and represents a basic and fully diluted loss per share of $(0.01). This compares to net loss of $698,000 in the same period last year, representing a basic and fully diluted loss per share of ($0.01). The Corporation has a cash balance of $5.2 million as at March 31, 2015.

    On a pro forma basis, assuming the previously announced acquisition of customer contracts and related people from The Innovation Group (LSE: TIG) that was completed March 31, 2015, had occurred January 1, 2015, revenue decreased to $5.9 million for the three months ending March 31, 2015. This compares to revenues of $7.2 million in the same period last year.

    The Corporation believes Adjusted EBITDA2 is also a useful measure as a proxy for operating cash flow and facilitates period-to-period operating comparisons. Pro forma Adjusted EBITDA for the three months ending March 31, 2015, was ($554,000) compared to Adjusted EBITDA of $808,000 in the same period last year.

    James Swayze, CEO of Symbility Solutions, commented:

    As we had announced at the beginning of 2014, our largest customer terminated at year-end which impacted our first quarter revenue. This customer, together with the supply chain, represented $10.3 million which effectively reset our revenue to $17.5 million to start 2015. While we knew it would be challenging to recoup this lost revenue in a single year, we are pleased to report that our first quarter financial results, together with the pro forma growth attributable to the business we acquired in the UK have us at a run rate of approximately $23.5 million with a more balanced customer concentration of 10 percent.

    Click here to read the full Symbility Solutions Inc. (TSXV:SY) press release.

    financial-results
    The Conversation (0)

    Go Deeper

    AI Powered

    Sezzle Reports Third Quarter 2025 Results

    Spectral Announces Third Quarter Results

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES